Literature DB >> 30689425

Gut Microbiota Involvement in Ventricular Remodeling Post-Myocardial Infarction.

Amy McMillan1,2, Stanley L Hazen1,2,3.   

Abstract

Entities:  

Keywords:  Editorials; anti-bacterial agents; cardiovascular diseases; fatty acids, volatile; gastrointestinal microbiome; heart failure; models, animal

Mesh：

Year:  2019        PMID： 30689425      PMCID： PMC6355251          DOI： 10.1161/CIRCULATIONAHA.118.037384

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  15 in total

1.  Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.

Authors:  Stephan von Haehling; Joerg C Schefold; Ewa A Jankowska; Jochen Springer; Ali Vazir; Paul R Kalra; Anja Sandek; Günter Fauler; Tatjana Stojakovic; Michael Trauner; Piotr Ponikowski; Hans-Dieter Volk; Wolfram Doehner; Andrew J S Coats; Philip A Poole-Wilson; Stefan D Anker
Journal:  J Am Coll Cardiol       Date:  2012-02-07       Impact factor: 24.094

2.  Probiotic therapy with Saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial.

Authors:  Annelise C Costanza; Samuel D Moscavitch; Hugo C C Faria Neto; Evandro T Mesquita
Journal:  Int J Cardiol       Date:  2014-11-11       Impact factor: 4.164

3.  Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair.

Authors:  Tony W H Tang; Hung-Chih Chen; Chen-Yun Chen; Christopher Y T Yen; Chen-Ju Lin; Ray P Prajnamitra; Li-Lun Chen; Shu-Chian Ruan; Jen-Hao Lin; Po-Ju Lin; Hsueh-Han Lu; Chiung-Wen Kuo; Cindy M Chang; Alexander D Hall; Eugenio I Vivas; Jr-Wen Shui; Peilin Chen; Timothy A Hacker; Federico E Rey; Timothy J Kamp; Patrick C H Hsieh
Journal:  Circulation       Date:  2019-01-29       Impact factor: 29.690

4.  Increased Secondary/Primary Bile Acid Ratio in Chronic Heart Failure.

Authors:  Cristiane C K Mayerhofer; Thor Ueland; Kaspar Broch; Royce P Vincent; Gemma F Cross; Christen P Dahl; Pål Aukrust; Lars Gullestad; Johannes R Hov; Marius Trøseid
Journal:  J Card Fail       Date:  2017-07-05       Impact factor: 5.712

5.  Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.

Authors:  Weifei Zhu; Jill C Gregory; Elin Org; Jennifer A Buffa; Nilaksh Gupta; Zeneng Wang; Lin Li; Xiaoming Fu; Yuping Wu; Margarete Mehrabian; R Balfour Sartor; Thomas M McIntyre; Roy L Silverstein; W H Wilson Tang; Joseph A DiDonato; J Mark Brown; Aldons J Lusis; Stanley L Hazen
Journal:  Cell       Date:  2016-03-10       Impact factor: 41.582

6.  Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial.

Authors:  Giampaolo Cerisano; Piergiovanni Buonamici; Renato Valenti; Roberto Sciagrà; Silvia Raspanti; Alberto Santini; Nazario Carrabba; Emilio Vincenzo Dovellini; Roberta Romito; Alberto Pupi; Paolo Colonna; David Antoniucci
Journal:  Eur Heart J       Date:  2013-10-08       Impact factor: 29.983

7.  Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat.

Authors:  Xiaohong Tracey Gan; Grace Ettinger; Cathy X Huang; Jeremy P Burton; James V Haist; Venkatesh Rajapurohitam; James E Sidaway; Glynn Martin; Gregory B Gloor; Jonathan R Swann; Gregor Reid; Morris Karmazyn
Journal:  Circ Heart Fail       Date:  2014-03-13       Impact factor: 8.790

8.  Choline Diet and Its Gut Microbe-Derived Metabolite, Trimethylamine N-Oxide, Exacerbate Pressure Overload-Induced Heart Failure.

Authors:  Chelsea L Organ; Hiroyuki Otsuka; Shashi Bhushan; Zeneng Wang; Jessica Bradley; Rishi Trivedi; David J Polhemus; W H Wilson Tang; Yuping Wu; Stanley L Hazen; David J Lefer
Journal:  Circ Heart Fail       Date:  2015-12-23       Impact factor: 8.790

9.  Intestinal Microbial Metabolites Are Linked to Severity of Myocardial Infarction in Rats.

Authors:  Vy Lam; Jidong Su; Anna Hsu; Garrett J Gross; Nita H Salzman; John E Baker
Journal:  PLoS One       Date:  2016-08-09       Impact factor: 3.240

10.  Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential.

Authors:  Adam B Roberts; Xiaodong Gu; Jennifer A Buffa; Alex G Hurd; Zeneng Wang; Weifei Zhu; Nilaksh Gupta; Sarah M Skye; David B Cody; Bruce S Levison; William T Barrington; Matthew W Russell; Jodie M Reed; Ashraf Duzan; Jennifer M Lang; Xiaoming Fu; Lin Li; Alex J Myers; Suguna Rachakonda; Joseph A DiDonato; J Mark Brown; Valentin Gogonea; Aldons J Lusis; Jose Carlos Garcia-Garcia; Stanley L Hazen
Journal:  Nat Med       Date:  2018-08-06       Impact factor: 53.440
View more
  10 in total

Review 1.  Mechanism and therapeutic strategies of depression after myocardial infarction.

Authors:  Ying Yang; Xuping Li; Sixuan Chen; Mingzhu Xiao; Zhongqiu Liu; Jingyan Li; Yuanyuan Cheng
Journal:  Psychopharmacology (Berl)       Date:  2021-02-16       Impact factor: 4.530

2.  Exosomes derived from human placental mesenchymal stem cells ameliorate myocardial infarction via anti-inflammation and restoring gut dysbiosis.

Authors:  Libo Yang; Ting Wang; Xiaoxia Zhang; Hua Zhang; Ning Yan; Guoshan Zhang; Ru Yan; Yiwei Li; Jingjing Yu; Jun He; Shaobin Jia; Hao Wang
Journal:  BMC Cardiovasc Disord       Date:  2022-02-17       Impact factor: 2.298

Review 3.  Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management?

Authors:  Khalid Mehmood; Afrasim Moin; Talib Hussain; Syed Mohd Danish Rizvi; D V Gowda; Shazi Shakil; M A Kamal
Journal:  Folia Microbiol (Praha)       Date:  2021-10-26       Impact factor: 2.099

4.  Gut microbiome mediates the protective effects of exercise after myocardial infarction.

Authors:  Qiulian Zhou; Jiali Deng; Xue Pan; Danni Meng; Yujiao Zhu; Yuzheng Bai; Chao Shi; Yi Duan; Tianhui Wang; Xinli Li; Joost Pg Sluijter; Junjie Xiao
Journal:  Microbiome       Date:  2022-05-31       Impact factor: 16.837

5.  Protective Effect of Lactobacillus rhamnosus GG and its Supernatant against Myocardial Dysfunction in Obese Mice Exposed to Intermittent Hypoxia is Associated with the Activation of Nrf2 Pathway.

Authors:  Hui Xu; Jiqun Wang; Jun Cai; Wenke Feng; Yonggang Wang; Quan Liu; Lu Cai
Journal:  Int J Biol Sci       Date:  2019-09-07       Impact factor: 6.580

Review 6.  Pharmacological Modulation of Cardiac Remodeling after Myocardial Infarction.

Authors:  Wei Zhao; Jia Zhao; Jianhui Rong
Journal:  Oxid Med Cell Longev       Date:  2020-12-30       Impact factor: 6.543

7.  Epigenetics, 1-Carbon Metabolism, and Homocysteine During Dysbiosis.

Authors:  Mahavir Singh; Shanna J Hardin; Akash K George; Wintana Eyob; Dragana Stanisic; Sathnur Pushpakumar; Suresh C Tyagi
Journal:  Front Physiol       Date:  2021-02-23       Impact factor: 4.566

Review 8.  Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease.

Authors:  Yingdong Lu; Yang Zhang; Xin Zhao; Chang Shang; Mi Xiang; Li Li; Xiangning Cui
Journal:  Front Cardiovasc Med       Date:  2022-08-11

Review 9.  The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.

Authors:  Marius Trøseid; Geir Øystein Andersen; Kaspar Broch; Johannes Roksund Hov
Journal:  EBioMedicine       Date:  2020-02-12       Impact factor: 8.143

10.  Mechanism of Blood-Heart-Barrier Leakage: Implications for COVID-19 Induced Cardiovascular Injury.

Authors:  Rubens P Homme; Akash K George; Mahavir Singh; Irina Smolenkova; Yuting Zheng; Sathnur Pushpakumar; Suresh C Tyagi
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.